%0 Conference Paper %1 fabre2018omtx705 %A Fabre, Myriam %A Ferrer, Cristina %A Dominguez-Hormaetxe, Saioa %A Kontermann, Roland %A Pfizenmaier, Klaus %A Seifert, Oliver %A Lopez-Casas, Pedro Pablo %A Abbas, Muhammad %A Richter, Wolfgang %A Simón, Laureano %A Hidalgo, Manuel %B Abstract Book of the 43rd ESMO Congress (ESMO 2018) %C Elsevier %D 2018 %I Oxford Univ. Press %K mult ubs_10004 ubs_20006 ubs_30063 ubs_40093 ubs_40096 unibibliografie wos %N 29, Suppl. 8 %P 414 %T OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments

@inproceedings{fabre2018omtx705, added-at = {2020-08-11T15:39:36.000+0200}, address = {Elsevier}, affiliation = {Fabre, M.; Ferrer, C.; Dominguez-Hormaetxe, S.; Simon, L., Oncomatryx Biopharma SL, R&D Dept, Derio, Spain. Kontermann, R.; Pfizenmaier, K.; Seifert, O., Stuttgart Univ, Inst Cell Biol & Immunol, Stuttgart, Germany. Lopez-Casas, P. P., CNIO, Gastrointestinal Canc Clin Res Unit, Madrid, Spain. Abbas, M.; Richter, W., Tube Pharmaceut GmBH, R&D Dept, Vienna, Austria. Hidalgo, M., Harvard Med Sch, Dept Med, Boston, MA 02115 USA.}, author = {Fabre, Myriam and Ferrer, Cristina and Dominguez-Hormaetxe, Saioa and Kontermann, Roland and Pfizenmaier, Klaus and Seifert, Oliver and Lopez-Casas, Pedro Pablo and Abbas, Muhammad and Richter, Wolfgang and Simón, Laureano and Hidalgo, Manuel}, biburl = {https://puma.ub.uni-stuttgart.de/bibtex/26468bb206310f8f60b46e88a1dda19ae/unibiblio}, booktitle = {Abstract Book of the 43rd ESMO Congress (ESMO 2018)}, eventdate = {2018-10-19/2018-10-23}, eventtitle = {43rd ESMO Congress (ESMO)}, howpublished = {Abstract}, interhash = {e4c4405041f63e012b76d6ce7a4ef5c3}, intrahash = {6468bb206310f8f60b46e88a1dda19ae}, keywords = {mult ubs_10004 ubs_20006 ubs_30063 ubs_40093 ubs_40096 unibibliografie wos}, language = {eng}, number = {29, Suppl. 8}, pages = 414, publisher = {Oxford Univ. Press}, research-areas = {Oncology}, series = {Annals of oncology}, timestamp = {2020-08-11T13:39:36.000+0200}, title = {OMTX705, a powerful stroma-targeting ADC to treat invasive tumors with low response to immunotherapeutic anti-PD-1 treatments}, unique-id = {ISI:000459277302340}, venue = {München}, year = 2018 }